Kodal Minerals PLC (LON: KOD) stock is up 10% this morning on an update to the company’s mining prospects in Mali. As a junior miner specialising in gold and lithium we can expect continued volatility in the share pric

Foghorn Therapeutics (NASDAQ: FHTX), a clinical-stage biotech company, has announced today that it has entered into a promising new partnership with Loxo Oncology at Lilly, a research and development group of Eli Lilly

One of the US’s leading chip manufacturers - Intel - announced today new plans for a chip factory in Malaysia. The company has stated the transaction will involve an investment of roughly $7B, with the target of expand

One of the most distinguished names in the world of two-wheelers, Harley Davidson (NYSE: HOG) is embracing the electric curve this morning with the announcement of LiveWire; the companies own electric-motorcycle divisi

As discussed last week, Lucid Group (NASDAQ: LCID) has been in bearish focus lately. With the SEC investigation and $2B in debt financing looming over bullish sentiment, Lucid stock plunged over 10% to round off last w

Arena Pharmaceuticals Inc (NASDAQ: ARNA) stock jumped 92% premarket this morning on the announcement of a takeover by Pfizer (NYSE: PFE). The buyout is at $100 a piece for the stock, a 100% premium to Friday’s closing

Capita PLC (LON: CPI) shares dropped 10 pence, or 21%, this morning on a trading statement showing no growth in gross revenues at the outsourcing giant. The long-awaited turnaround is taking longer to arrive than hoped

On some tickers, Lloyds Banking Group PLC (LON: LLOY) is up 45% this morning. This is not, sadly, the grand victory for long-suffering shareholders that we might hope. This is a technical issue to do with the ADRs repr

Simec Atlantis Energy — the developer of renewable and sustainable energy projects — said Monday that it has agreed to sell its subsidiary Green Highlands Renewables (GHR) for £3 million.

The Purplebricks Group PLC (LON: PURP) share price has fallen 18% this morning on worries about compensation payouts that might be necessary. This is just the latest worry to afflict Purplebricks, the game-changing est

Both DeepVerge (LON: DVRG) and Microsaic Systems (LON: MSYS) have seen their shares rise Monday after announcing

The Bidstack Group PLC (LON: BIDS) share price soared 125% on the back of news with a deal with an “AAA Game Publisher” the company announced Friday. The Bidstack stock is off 10% this morning as the market waits for m

4D Pharma (LON: DDDD) shares have rallied Monday morning on the back of positive data from the

Moderna (NASDAQ: MRNA) stock had a difficult time in Friday’s trading after a report illustrating early data from the company’s mRNA-based vaccine showed it to be no more effective than shots already on market. The rep

Peloton (NASDAQ: PTON) stock has had a whirlwind couple of years. It seems now however that, once the pandemic fog starts to bring clarity back to normality, people go about their normal lives - of which the gym is a s

Broadcom (NASDAQ: AVGO) stock was up 7.3% with Friday’s opening market bells after the company released Q4 results that topped analyst estimates, bolstering AVGO’s momentum as the semiconductor stock continues to make

C3Ai Inc (NYSE: AI) stock price rallied 21.4% after signing a production- other transaction agreement (OTA) worth $500 million with the US Department of Defence to give them access to a suite of enterprise artificial intelligence products and service

Stock in Oracle Corp (NYSE: ORCL) rallied just over 14% in Friday premarket trading, soaring past all-time highs as the company posts better-than-expected Q2 earnings, with the cloud services industry continuing to be

Mesa Air Group Inc (NASDAQ: MESA) stock price fell 16.8% during premarket trading after Michael Linenberg, an analyst at Deutsche Bank, downgraded the airline to a hold from a buy and lowered his price target to $7 from $15. The analyst cited the

Context Therapeutics Inc (NASDAQ: CNTX) soared 33.9% after announcing positive data from its window-of-opportunity clinical trial of onapristone extended-release (ONA-XR) in patients with early breast cancer who are past menopause. The clinical tr